We are live on ! Find out more
LCM

Lazari Capital Management Portfolio holdings

AUM $325M
1-Year Est. Return 32.83%
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
+32.83%
3 Year Est. Return
+124.01%
5 Year Est. Return
10 Year Est. Return
AUM
$325M
AUM Growth
+$37.2M
Cap. Flow
+$6.76M
Cap. Flow %
2.08%
Top 10 Hldgs %
52.12%
Holding
198
New
23
Increased
73
Reduced
67
Closed
10

Top Sells

Rank Stock Value
1
SRE icon
Sempra
SRE
+$2.36M
2
AVGO icon
Broadcom
AVGO
+$521K
3
AMD icon
Advanced Micro Devices
AMD
+$465K
4
AAPL icon
Apple
AAPL
+$444K
5
V icon
Visa
V
+$336K

Sector Composition

Rank Sector Weight
1 Technology 34.91%
2 Communication Services 17.11%
3 Consumer Discretionary 10.57%
4 Financials 6.71%
5 Healthcare 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUG icon
176
Plug Power
PLUG
$2.87B
$110K 0.03%
40,748
+3,950
+11% +$12.4K
SOUN icon
177
SoundHound AI
SOUN
$2.67B
$108K 0.03%
+16,755
New +$130K
LYG icon
178
Lloyds Banking Group
LYG
$89.5B
$105K 0.03%
17,949
BITU icon
179
ProShares Ultra Bitcoin ETF
BITU
$339M
$81.2K 0.03%
+10,000
New +$128K
PPT
180
Franklin Premier Income Trust
PPT
$324M
$78.3K 0.02%
22,436
MBOT icon
181
Microbot Medical
MBOT
$116M
$71.4K 0.02%
36,600
+13,345
+57% +$27.2K
TMC icon
182
TMC The Metals Company
TMC
$1.54B
$44.3K 0.01%
10,000
MAIA icon
183
MAIA Biotechnology
MAIA
$76M
$31.3K 0.01%
+21,750
New +$28.9K
RR icon
184
Richtech Robotics
RR
$318M
$28.5K 0.01%
+13,500
New +$32.8K
KSCP icon
185
Knightscope
KSCP
$28.3M
$24.1K 0.01%
+11,400
New +$32.3K
LCTX icon
186
Lineage Cell Therapeutics
LCTX
$269M
$13.8K ﹤0.01%
10,500
VANI icon
187
Vivani Medical
VANI
$110M
$12.4K ﹤0.01%
10,000
HUMA icon
188
Humacyte
HUMA
$176M
$11.3K ﹤0.01%
14,444
+1,300
+10% +$1.21K
CZR icon
189
Caesars Entertainment
CZR
$6.06B
-8,900
Closed -$235K
GILD icon
190
Gilead Sciences
GILD
$162B
-1,892
Closed -$264K
HON icon
191
Honeywell
HON
$77B
-979
Closed -$221K
IMO icon
192
Imperial Oil
IMO
$62.7B
-1,670
Closed -$218K
LMT icon
193
Lockheed Martin
LMT
$134B
-354
Closed -$214K
PFF icon
194
iShares Preferred and Income Securities ETF
PFF
$13.3B
-7,167
Closed -$217K
SHEL icon
195
Shell
SHEL
$254B
-2,385
Closed -$222K
SRE icon
196
Sempra
SRE
$57.9B
-24,302
Closed -$2.36M
VALE icon
197
Vale
VALE
$64.1B
-10,506
Closed -$167K
WM icon
198
Waste Management
WM
$90.6B
-890
Closed -$205K

Similar funds

Lazari Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Lazari Capital Management held 198 positions worth $325M, up 13% from $287M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Lazari Capital Management's Q2 2026 filing shows 23 new, 73 increased, 67 reduced and 10 closed positions. Its largest new stake was Oracle Corp Preferred Stock Series D: 17,800 shares worth $800K. The largest sale was Sempra, an estimated $2.36M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Lazari Capital Management's largest Q2 2026 buy was Oracle Corp Preferred Stock Series D: 17,800 shares worth $800K.
  • Lazari Capital Management added most to NVIDIA in Q2 2026, an estimated $1.61M increase.
  • Lazari Capital Management's biggest Q2 2026 reduction was Broadcom, cutting an estimated $521K.
  • Lazari Capital Management fully exited Sempra in Q2 2026, selling an estimated $2.36M.
  • Lazari Capital Management's ten largest holdings make up 52% of its $325M portfolio in Q2 2026.
  • Lazari Capital Management opened 23 new positions and closed 10 in Q2 2026.
  • Lazari Capital Management's portfolio value rose 13% quarter-over-quarter to $325M.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.